I did to listen to NP again. I believe he said they were going to start with mild or moderate symptoms? If so, they key is seeing if the percent that develop ARDS is lower in the leronlimab group. I assume at some point the immune system has already done to much damage to recover, so the earlier in treatment the better imo.